AAAAAA
Results: 101-125/366
Authors:
SCHULZ WA
KRUMMECK A
ROSINGER I
EICKELMANN P
NEUHAUS C
EBERT T
SCHMITZDRAGER BJ
SIES H
Citation: Wa. Schulz et al., INCREASED FREQUENCY OF A NULL-ALLELE FOR NAD(P)H - QUINONE OXIDOREDUCTASE IN PATIENTS WITH UROLOGICAL MALIGNANCIES, Pharmacogenetics, 7(3), 1997, pp. 235-239
Authors:
MEISEL P
SCHROEDER C
WULFF K
SIEGMUND W
Citation: P. Meisel et al., RELATIONSHIP BETWEEN HUMAN GENOTYPE AND PHENOTYPE OF N-ACETYLTRANSFERASE (NAT2) AS ESTIMATED BY DISCRIMINANT-ANALYSIS AND MULTIPLE LINEAR-REGRESSION .1. GENOTYPE AND N-ACETYLATION IN-VIVO, Pharmacogenetics, 7(3), 1997, pp. 241-246
Authors:
GULLSTEN H
AGUNDEZ JAG
BENITEZ J
LAARA E
LADERO JM
DIAZRUBIO M
FERNANDEZSALGUERO P
GONZALEZ F
RAUTIO A
PELKONEN O
RAUNIO H
Citation: H. Gullsten et al., CYP2A6 GENE POLYMORPHISM AND RISK OF LIVER-CANCER AND CIRRHOSIS, Pharmacogenetics, 7(3), 1997, pp. 247-250
Authors:
BECQUEMONT L
LECOEUR S
SIMON T
BEAUNE P
FUNCKBRENTANO C
JAILLON P
Citation: L. Becquemont et al., GLUTATHIONE-S-TRANSFERASE-THETA GENETIC-POLYMORPHISM MIGHT INFLUENCE TACRINE HEPATOTOXICITY IN ALZHEIMERS PATIENTS, Pharmacogenetics, 7(3), 1997, pp. 251-253
Authors:
MARTINEZ C
AGUNDEZ JAG
GERVASINI G
MARTIN R
BENITEZ J
Citation: C. Martinez et al., TRYPTAMINE - A POSSIBLE ENDOGENOUS SUBSTRATE FOR CYP2D6, Pharmacogenetics, 7(2), 1997, pp. 85-93
Authors:
MARTINEZ C
AGUNDEZ JAG
GERVASINI G
MARTIN R
BENITEZ J
Citation: C. Martinez et al., TRYPTAMINE - A POSSIBLE ENDOGENOUS SUBSTRATE FOR CYP2D6, Pharmacogenetics, 7(2), 1997, pp. 85-93
Authors:
MICKA J
MILATOVICH A
MENON A
GRABOWSKI GA
PUGA A
NEBERT DW
Citation: J. Micka et al., HUMAN AH RECEPTOR (AHR) GENE - LOCALIZATION TO 7P15 AND SUGGESTIVE CORRELATION OF POLYMORPHISM WITH CYP1A1 INDUCIBILITY, Pharmacogenetics, 7(2), 1997, pp. 95-101
Authors:
MICKA J
MILATOVICH A
MENON A
GRABOWSKI GA
PUGA A
NEBERT DW
Citation: J. Micka et al., HUMAN AH RECEPTOR (AHR) GENE - LOCALIZATION TO 7P15 AND SUGGESTIVE CORRELATION OF POLYMORPHISM WITH CYP1A1 INDUCIBILITY, Pharmacogenetics, 7(2), 1997, pp. 95-101
Authors:
INOUE K
YAMAZAKI H
IMIYA K
AKASAKA S
GUENGERICH FP
SHIMADA T
Citation: K. Inoue et al., RELATIONSHIP BETWEEN CYP2C9 AND 2C19 GENOTYPES AND TOLBUTAMIDE METHYLHYDROXYLATION AND S-MEPHENYTOIN 4'-HYDROXYLATION ACTIVITIES IN LIVERSOF JAPANESE AND CAUCASIAN POPULATIONS, Pharmacogenetics, 7(2), 1997, pp. 103-113
Authors:
INOUE K
YAMAZAKI H
IMIYA K
AKASAKA S
GUENGERICH FP
SHIMADA T
Citation: K. Inoue et al., RELATIONSHIP BETWEEN CYP2C9 AND 2C19 GENOTYPES AND TOLBUTAMIDE METHYLHYDROXYLATION AND S-MEPHENYTOIN 4'-HYDROXYLATION ACTIVITIES IN LIVERSOF JAPANESE AND CAUCASIAN POPULATIONS, Pharmacogenetics, 7(2), 1997, pp. 103-113
Authors:
XIE HG
HUANG SL
XU ZH
XIAO XS
HE N
ZHOU HH
Citation: Hg. Xie et al., EVIDENCE FOR THE EFFECT OF GENDER ON ACTIVITY OF (S)-MEPHENYTOIN 4'-HYDROXYLASE (CYP2C19) IN A CHINESE POPULATION, Pharmacogenetics, 7(2), 1997, pp. 115-119
Authors:
XIE HG
HUANG SL
XU ZH
XIAO XS
HE N
ZHOU HH
Citation: Hg. Xie et al., EVIDENCE FOR THE EFFECT OF GENDER ON ACTIVITY OF (S)-MEPHENYTOIN 4'-HYDROXYLASE (CYP2C19) IN A CHINESE POPULATION, Pharmacogenetics, 7(2), 1997, pp. 115-119
Authors:
STANLEY LA
MILLS IG
SIM E
Citation: La. Stanley et al., LOCALIZATION OF POLYMORPHIC N-ACETYLTRANSFERASE (NAT2) IN TISSUES OF INBRED MICE, Pharmacogenetics, 7(2), 1997, pp. 121-130
Authors:
STANLEY LA
MILLS IG
SIM E
Citation: La. Stanley et al., LOCALIZATION OF POLYMORPHIC N-ACETYLTRANSFERASE (NAT2) IN TISSUES OF INBRED MICE, Pharmacogenetics, 7(2), 1997, pp. 121-130
Authors:
SABBAGH N
DELAPORTE E
MAREZ D
LOGUIDICE JM
PIETTE F
BROLY F
Citation: N. Sabbagh et al., NAT2 GENOTYPING AND EFFICACY OF SULFASALAZINE IN PATIENTS WITH CHRONIC DISCOID LUPUS-ERYTHEMATOSUS, Pharmacogenetics, 7(2), 1997, pp. 131-135
Authors:
SABBAGH N
DELAPORTE E
MAREZ D
LOGUIDICE JM
PIETTE F
BROLY F
Citation: N. Sabbagh et al., NAT2 GENOTYPING AND EFFICACY OF SULFASALAZINE IN PATIENTS WITH CHRONIC DISCOID LUPUS-ERYTHEMATOSUS, Pharmacogenetics, 7(2), 1997, pp. 131-135
Authors:
LI WF
MATTHEWS C
DISTECHE CM
COSTA LG
FURLONG CE
Citation: Wf. Li et al., PARAOXONASE (PON1) GENE IN MICE - SEQUENCING, CHROMOSOMAL LOCALIZATION AND DEVELOPMENTAL EXPRESSION, Pharmacogenetics, 7(2), 1997, pp. 137-144
Authors:
LI WF
MATTHEWS C
DISTECHE CM
COSTA LG
FURLONG CE
Citation: Wf. Li et al., PARAOXONASE (PON1) GENE IN MICE - SEQUENCING, CHROMOSOMAL LOCALIZATION AND DEVELOPMENTAL EXPRESSION, Pharmacogenetics, 7(2), 1997, pp. 137-144
Authors:
NOWAK MP
TYNDALE RF
SELLERS EM
Citation: Mp. Nowak et al., CYP2D6 PHENOTYPE AND GENOTYPE IN A CANADIAN NATIVE INDIAN POPULATION, Pharmacogenetics, 7(2), 1997, pp. 145-148
Authors:
NOWAK MP
TYNDALE RF
SELLERS EM
Citation: Mp. Nowak et al., CYP2D6 PHENOTYPE AND GENOTYPE IN A CANADIAN NATIVE INDIAN POPULATION, Pharmacogenetics, 7(2), 1997, pp. 145-148
Authors:
LOVLIE R
DALY AK
IDLE JR
STEEN VM
Citation: R. Lovlie et al., CHARACTERIZATION OF THE 16-KB AND 30+9-KB CYP2D6-XBAI-HAPLOTYPES(9), Pharmacogenetics, 7(2), 1997, pp. 149-152
Authors:
LOVLIE R
DALY AK
IDLE JR
STEEN VM
Citation: R. Lovlie et al., CHARACTERIZATION OF THE 16-KB AND 30+9-KB CYP2D6-XBAI-HAPLOTYPES(9), Pharmacogenetics, 7(2), 1997, pp. 149-152
Authors:
MONAGHAN G
FOSTER B
JURIMAROMET M
HUME R
BURCHELL B
Citation: G. Monaghan et al., UGT1-ASTERISK-1-GENOTYPING IN A CANADIAN INUIT POPULATION, Pharmacogenetics, 7(2), 1997, pp. 153-156
Authors:
MONAGHAN G
FOSTER B
JURIMAROMET M
HUME R
BURCHELL B
Citation: G. Monaghan et al., UGT1-ASTERISK-1-GENOTYPING IN A CANADIAN INUIT POPULATION, Pharmacogenetics, 7(2), 1997, pp. 153-156
Authors:
BENHAMOU S
BOUCHARDY C
DAYER P
Citation: S. Benhamou et al., LUNG-CANCER RISK IN RELATION TO MEPHENYTOIN HYDROXYLATION ACTIVITY, Pharmacogenetics, 7(2), 1997, pp. 157-159